This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Björck M, Earnshaw JJ, Acosta S, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur J Vasc Endovasc Surg. 2020;59(2):173–218. doi: 10.1016/j.ejvs.2019.09.006BjörckMEarnshawJJAcostaSEditor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia202059217321810.1016/j.ejvs.2019.09.006Open DOISearch in Google Scholar
Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S–125S.e40. doi: 10.1016/j.jvs.2019.02.016ConteMSBradburyAWKolhPGlobal vascular guidelines on the management of chronic limb-threatening ischemia2019696S3S125S.e4010.1016/j.jvs.2019.02.016Open DOISearch in Google Scholar
Lisman T. Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease. Cell Tissue Res. 2018;371(3):567–576. doi: 10.1007/s00441-017-2727-4LismanTPlatelet-neutrophil interactions as drivers of inflammatory and thrombotic disease2018371356757610.1007/s00441-017-2727-4Open DOISearch in Google Scholar
Jakobsson G, Papareddy P, Andersson H, et al. Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction. Critical Care. 2023;27(1):374. doi: 10.1186/s13054-023-04652-xJakobssonGPapareddyPAnderssonHTherapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction202327137410.1186/s13054-023-04652-xOpen DOISearch in Google Scholar
Boteanu RM, Suica VI, Uyy E, et al. Short-Term Blockade of Pro-Inflammatory Alarmin S100A9 Favorably Modulates Left Ventricle Proteome and Related Signaling Pathways Involved in Post-Myocardial Infarction Recovery. Int J Mol Sci. 2022;23(9):5289. doi: 10.3390/ijms23095289BoteanuRMSuicaVIUyyEShort-Term Blockade of Pro-Inflammatory Alarmin S100A9 Favorably Modulates Left Ventricle Proteome and Related Signaling Pathways Involved in Post-Myocardial Infarction Recovery2022239528910.3390/ijms23095289Open DOISearch in Google Scholar
Marinković G, Koenis DS, de Camp L, et al. S100A9 Links Inflammation and Repair in Myocardial Infarction. Circ Res. 2020;127(5):664–676. doi: 10.1161/CIRCRESAHA.120.315865MarinkovićGKoenisDSde CampLS100A9 Links Inflammation and Repair in Myocardial Infarction2020127566467610.1161/CIRCRESAHA.120.315865Open DOISearch in Google Scholar
Zuidema MY, Zhang C. Ischemia/reperfusion injury: The role of immune cells. World J Cardiol. 2010;2(10):325–332. doi: 10.4330/wjc.v2.i10.325ZuidemaMYZhangCIschemia/reperfusion injury: The role of immune cells201021032533210.4330/wjc.v2.i10.325Open DOISearch in Google Scholar
Stabile E, Kinnaird T, la Sala A, et al. CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16. Circulation. 2006;113(1):118–124. doi: 10.1161/CIRCULATIONAHA.105.576702StabileEKinnairdTla SalaACD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-162006113111812410.1161/CIRCULATIONAHA.105.576702Open DOISearch in Google Scholar
Kaller R, Russu E, Arbănași EM, et al. Intimal CD31-Positive Relative Surfaces Are Associated with Systemic Inflammatory Markers and Maturation of Arteriovenous Fistula in Dialysis Patients. Journal of Clinical Medicine. 2023;12(13):4419. doi: 10.3390/jcm12134419KallerRRussuEArbănașiEMIntimal CD31-Positive Relative Surfaces Are Associated with Systemic Inflammatory Markers and Maturation of Arteriovenous Fistula in Dialysis Patients20231213441910.3390/jcm12134419Open DOISearch in Google Scholar
Mureșan AV, Russu E, Arbănași EM, et al. The Predictive Value of NLR, MLR, and PLR in the Outcome of End-Stage Kidney Disease Patients. Biomedicines. 2022;10(6):1272. doi: 10.3390/biomedicines10061272MureșanAVRussuEArbănașiEMThe Predictive Value of NLR, MLR, and PLR in the Outcome of End-Stage Kidney Disease Patients2022106127210.3390/biomedicines10061272Open DOISearch in Google Scholar
Kaller R, Arbănași EM, Mureșan AV, et al. The Predictive Value of Systemic Inflammatory Markers, the Prognostic Nutritional Index, and Measured Vessels' Diameters in Arteriovenous Fistula Maturation Failure. Life. 2022;12(9):1447. doi: 10.3390/life12091447KallerRArbănașiEMMureșanAVThe Predictive Value of Systemic Inflammatory Markers, the Prognostic Nutritional Index, and Measured Vessels' Diameters in Arteriovenous Fistula Maturation Failure2022129144710.3390/life12091447Open DOISearch in Google Scholar
Niculescu R, Russu E, Arbănași EM, et al. Carotid Plaque Features and Inflammatory Biomarkers as Predictors of Restenosis and Mortality Following Carotid Endarterectomy. International Journal of Environmental Research and Public Health. 2022;19(21):13934. doi: 10.3390/ijerph192113934NiculescuRRussuEArbănașiEMCarotid Plaque Features and Inflammatory Biomarkers as Predictors of Restenosis and Mortality Following Carotid Endarterectomy202219211393410.3390/ijerph192113934Open DOISearch in Google Scholar
Arbănași EM, Mureșan AV, Arbănași EM, et al. The Neutrophilto-Lymphocyte Ratio's Predictive Utility in Acute Pulmonary Embolism: Systematic Review. Journal of Cardiovascular Emergencies. 2022;8:25–30. doi: 10.2478/jce-2022-0005ArbănașiEMMureșanAVArbănașiEMThe Neutrophilto-Lymphocyte Ratio's Predictive Utility in Acute Pulmonary Embolism: Systematic Review20228253010.2478/jce-2022-0005Open DOISearch in Google Scholar
Mureșan AV, Hălmaciu I, Arbănași EM, et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(11):2757. doi: 10.3390/diagnostics12112757MureșanAVHălmaciuIArbănașiEMPrognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients20221211275710.3390/diagnostics12112757Open DOISearch in Google Scholar
Halmaciu I, Arbănași EM, Kaller R, et al. Chest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients' Mortality. Diagnostics. 2022;12(9):2089. doi: 10.3390/diagnostics12092089HalmaciuIArbănașiEMKallerRChest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients' Mortality2022129208910.3390/diagnostics12092089Open DOISearch in Google Scholar
Arbănași EM, Halmaciu I, Kaller R, et al. Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(10):2379. doi: 10.3390/diagnostics12102379ArbănașiEMHalmaciuIKallerRSystemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients20221210237910.3390/diagnostics12102379Open DOISearch in Google Scholar
Melinte RM, Arbănași EM, Blesneac A, et al. Inflammatory Biomarkers as Prognostic Factors of Acute Deep Vein Thrombosis Following the Total Knee Arthroplasty. Medicina. 2022;58(10):1502. doi: 10.3390/medicina58101502MelinteRMArbănașiEMBlesneacAInflammatory Biomarkers as Prognostic Factors of Acute Deep Vein Thrombosis Following the Total Knee Arthroplasty20225810150210.3390/medicina58101502Open DOISearch in Google Scholar
Vunvulea V, Budișcă OA, Arbănași EM, et al. The Predictive Role of Systemic Inflammatory Markers in the Development of Acute Kidney Failure and Mortality in Patients with Abdominal Trauma. Journal of Personalized Medicine. 2022;12(12):2045. doi: 10.3390/jpm12122045VunvuleaVBudișcăOAArbănașiEMThe Predictive Role of Systemic Inflammatory Markers in the Development of Acute Kidney Failure and Mortality in Patients with Abdominal Trauma20221212204510.3390/jpm12122045Open DOISearch in Google Scholar
Arbănași EM, Kaller R, Mureșan AV, Voidăzan S, Arbanasi EM, Russu E. Impact of COVID-19 pandemic on Vascular Surgery Unit activity in Central Romania. Front Surg. 2022;9:883935. doi: 10.3389/fsurg.2022.883935ArbănașiEMKallerRMureșanAVVoidăzanSArbanasiEMRussuEImpact of COVID-19 pandemic on Vascular Surgery Unit activity in Central Romania2022988393510.3389/fsurg.2022.883935Open DOISearch in Google Scholar
Hodas R, Benedek I, Rat N, Kovacs I, Chitu M, Benedek T. Impact of COVID-19 Pandemic on STEMI Networks in Central Romania. Life. 2021;11(10):1004. doi: 10.3390/life11101004HodasRBenedekIRatNKovacsIChituMBenedekTImpact of COVID-19 Pandemic on STEMI Networks in Central Romania20211110100410.3390/life11101004Open DOISearch in Google Scholar
Bhargavan B, Kanmogne GD. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for the Pathogenesis of COVID-19 Coagulopathy. Int J Mol Sci. 2023;24(16):12585. doi: 10.3390/ijms241612585BhargavanBKanmogneGDSARS-CoV-2 Spike Proteins and Cell-Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for the Pathogenesis of COVID-19 Coagulopathy202324161258510.3390/ijms241612585Open DOISearch in Google Scholar
Mátyás BB, Benedek I, Blîndu E, et al. Elevated FAI Index of Pericoronary Inflammation on Coronary CT Identifies Increased Risk of Coronary Plaque Vulnerability after COVID-19 Infection. Int J Mol Sci. 2023;24(8):7398. doi: 10.3390/ijms24087398MátyásBBBenedekIBlînduEElevated FAI Index of Pericoronary Inflammation on Coronary CT Identifies Increased Risk of Coronary Plaque Vulnerability after COVID-19 Infection2023248739810.3390/ijms24087398Open DOISearch in Google Scholar
Ranucci M, Baryshnikova E, Anguissola M, Pugliese S, Falco M, Menicanti L. The Long Term Residual Effects of COVID-Associated Coagulopathy. International Journal of Molecular Sciences. 2023;24(6):5514. doi: 10.3390/ijms24065514RanucciMBaryshnikovaEAnguissolaMPuglieseSFalcoMMenicantiLThe Long Term Residual Effects of COVID-Associated Coagulopathy2023246551410.3390/ijms24065514Open DOISearch in Google Scholar
Szilveszter M, Pál S, Simon-Szabó Z, et al. The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases. International Journal of Molecular Sciences. 2023;24(16):12782. doi: 10.3390/ijms241612782SzilveszterMPálSSimon-SzabóZThe Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases202324161278210.3390/ijms241612782Open DOISearch in Google Scholar
Ragnoli B, Da Re B, Galantino A, Kette S, Salotti A, Malerba M. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence. Int J Mol Sci. 2023;24(10):8945. doi: 10.3390/ijms24108945RagnoliBDa ReBGalantinoAKetteSSalottiAMalerbaMInterrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence20232410894510.3390/ijms24108945Open DOISearch in Google Scholar
Wada H, Shiraki K, Shimpo H, Shimaoka M, Iba T, Suzuki-Inoue K. Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019. International Journal of Molecular Sciences. 2023;24(9):7975. doi: 10.3390/ijms24097975WadaHShirakiKShimpoHShimaokaMIbaTSuzuki-InoueKThrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 20192023249797510.3390/ijms24097975Open DOISearch in Google Scholar
Taşoğlu I, Çiçek OF, Lafci G, et al. Usefulness of neutrophil/lymphocyte ratio as a predictor of amputation after embolectomy for acute limb ischemia. Ann Vasc Surg. 2014;28(3):606–613. doi: 10.1016/j.avsg.2012.12.009TaşoğluIÇiçekOFLafciGUsefulness of neutrophil/lymphocyte ratio as a predictor of amputation after embolectomy for acute limb ischemia201428360661310.1016/j.avsg.2012.12.009Open DOISearch in Google Scholar
Coelho NH, Coelho A, Augusto R, et al. Pre-operative Neutrophil to Lymphocyte Ratio is Associated With 30 Day Death or Amputation After Revascularisation for Acute Limb Ischaemia. Eur J Vasc Endovasc Surg. 2021;62(1):74–80. doi: 10.1016/j.ejvs.2021.03.011CoelhoNHCoelhoAAugustoRPre-operative Neutrophil to Lymphocyte Ratio is Associated With 30 Day Death or Amputation After Revascularisation for Acute Limb Ischaemia2021621748010.1016/j.ejvs.2021.03.011Open DOISearch in Google Scholar
Taurino M, Aloisi F, Del Porto F, et al. Neutrophil-to-Lymphocyte Ratio Could Predict Outcome in Patients Presenting with Acute Limb Ischemia. Journal of Clinical Medicine. 2021;10(19):4343. doi: 10.3390/jcm10194343TaurinoMAloisiFDel PortoFNeutrophil-to-Lymphocyte Ratio Could Predict Outcome in Patients Presenting with Acute Limb Ischemia20211019434310.3390/jcm10194343Open DOISearch in Google Scholar
Pasqui E, de Donato G, Giannace G, et al. The relation between neutrophil/lymphocyte and platelet/lymphocyte ratios with mortality and limb amputation after acute limb ischaemia. Vascular. 2022;30(2):267–275. doi: 10.1177/17085381211010012PasquiEde DonatoGGiannaceGThe relation between neutrophil/lymphocyte and platelet/lymphocyte ratios with mortality and limb amputation after acute limb ischaemia202230226727510.1177/17085381211010012Open DOISearch in Google Scholar
Arbănași EM, Mureșan AV, Coșarcă CM, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Impact on Predicting Outcomes in Patients with Acute Limb Ischemia. Life. 2022;12(6):822. doi: 10.3390/life12060822ArbănașiEMMureșanAVCoșarcăCMNeutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Impact on Predicting Outcomes in Patients with Acute Limb Ischemia202212682210.3390/life12060822Open DOISearch in Google Scholar
Spark JI, Sarveswaran J, Blest N, Charalabidis P, Asthana S. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. Journal of Vascular Surgery. 2010;52(3):632–636. doi: 10.1016/j.jvs.2010.03.067SparkJISarveswaranJBlestNCharalabidisPAsthanaSAn elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia201052363263610.1016/j.jvs.2010.03.067Open DOISearch in Google Scholar
Chan C, Puckridge P, Ullah S, Delaney C, Spark JI. Neutrophil-lymphocyte ratio as a prognostic marker of outcome in infrapopliteal percutaneous interventions for critical limb ischemia. Journal of Vascular Surgery. 2014;60(3):661–668. doi: 10.1016/j.jvs.2014.03.277ChanCPuckridgePUllahSDelaneyCSparkJINeutrophil-lymphocyte ratio as a prognostic marker of outcome in infrapopliteal percutaneous interventions for critical limb ischemia201460366166810.1016/j.jvs.2014.03.277Open DOISearch in Google Scholar
González-Fajardo JA, Brizuela-Sanz JA, Aguirre-Gervás B, et al. Prognostic Significance of an Elevated Neutrophil–Lymphocyte Ratio in the Amputation-free Survival of Patients with Chronic Critical Limb Ischemia. Annals of Vascular Surgery. 2014;28(4):999–1004. doi: 10.1016/j.avsg.2013.06.037González-FajardoJABrizuela-SanzJAAguirre-GervásBPrognostic Significance of an Elevated Neutrophil–Lymphocyte Ratio in the Amputation-free Survival of Patients with Chronic Critical Limb Ischemia2014284999100410.1016/j.avsg.2013.06.037Open DOISearch in Google Scholar
Erturk M, Cakmak HA, Surgit O, et al. Predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease. J Cardiol. 2014;64(5):371–376. doi: 10.1016/j.jjcc.2014.02.019ErturkMCakmakHASurgitOPredictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease201464537137610.1016/j.jjcc.2014.02.019Open DOISearch in Google Scholar
Taşoğlu İ, Sert D, Colak N, Uzun A, Songur M, Ecevit A. Neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia. Clin Appl Thromb Hemost. 2014;20(6):645–650. doi: 10.1177/1076029613475474TaşoğluİSertDColakNUzunASongurMEcevitANeutrophil-lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia201420664565010.1177/1076029613475474Open DOISearch in Google Scholar
Su MI, Liu CW. Neutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia. PLOS ONE. 2021;16(5):e0252030. doi: 10.1371/journal.pone.0252030SuMILiuCWNeutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia2021165e025203010.1371/journal.pone.0252030Open DOISearch in Google Scholar
Russu E, Mureșan AV, Arbănași EM, et al. The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease. Journal of Clinical Medicine. 2022;11(9):2620. doi: 10.3390/jcm11092620RussuEMureșanAVArbănașiEMThe Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease2022119262010.3390/jcm11092620Open DOISearch in Google Scholar
Chen C, Gu L, Chen L, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Potential Predictors of Prognosis in Acute Ischemic Stroke. Front Neurol. 2021;11:525621. doi: 10.3389/fneur.2020.525621ChenCGuLChenLNeutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Potential Predictors of Prognosis in Acute Ischemic Stroke20211152562110.3389/fneur.2020.525621Open DOISearch in Google Scholar
Brooks SD, Spears C, Cummings C, et al. Admission neutrophil–lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy. J Neurointerv Surg. 2014;6(8):578–583. doi: 10.1136/neurintsurg-2013-010780BrooksSDSpearsCCummingsCAdmission neutrophil–lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy20146857858310.1136/neurintsurg-2013-010780Open DOISearch in Google Scholar
Xu C, Cai L, Yi T, Yi X, Hu Y. Neutrophil-to-lymphocyte ratio is associated with stroke progression and functional outcome in patients with ischemic stroke. Brain Behav. 2023;13(11):e3261. doi: 10.1002/brb3.3261XuCCaiLYiTYiXHuYNeutrophil-to-lymphocyte ratio is associated with stroke progression and functional outcome in patients with ischemic stroke20231311e326110.1002/brb3.3261Open DOISearch in Google Scholar
Kordzadeh A, Malietzis G, Browne T, Prionidis I, Panayiotopoulos YP. Neutrophil to lymphocyte ratio (NLR) of five predicts 30-day morbidity in ruptured abdominal aortic aneurysms (rAAA): A retrospective cohort study. Int J Surg. 2015;15:45–48. doi: 10.1016/j.ijsu.2015.01.013KordzadehAMalietzisGBrowneTPrionidisIPanayiotopoulosYPNeutrophil to lymphocyte ratio (NLR) of five predicts 30-day morbidity in ruptured abdominal aortic aneurysms (rAAA): A retrospective cohort study201515454810.1016/j.ijsu.2015.01.013Open DOISearch in Google Scholar
Aurelian SV, Adrian M, Andercou O, et al. Neutrophil-to-Lymphocyte Ratio: A Comparative Study of Rupture to Nonruptured Infrarenal Abdominal Aortic Aneurysm. Ann Vasc Surg. 2019;58:270–275. doi: 10.1016/j.avsg.2018.11.026AurelianSVAdrianMAndercouONeutrophil-to-Lymphocyte Ratio: A Comparative Study of Rupture to Nonruptured Infrarenal Abdominal Aortic Aneurysm20195827027510.1016/j.avsg.2018.11.026Open DOISearch in Google Scholar
Appleton ND, Bailey DM, Morris-Stiff G, Lewis MH. Neutrophil to Lymphocyte Ratio Predicts Perioperative Mortality Following Open Elective Repair of Abdominal Aortic Aneurysms. Vasc Endovasc Surg. 2014;48(4):311–316. doi: 10.1177/1538574413519713AppletonNDBaileyDMMorris-StiffGLewisMHNeutrophil to Lymphocyte Ratio Predicts Perioperative Mortality Following Open Elective Repair of Abdominal Aortic Aneurysms201448431131610.1177/1538574413519713Open DOISearch in Google Scholar
Mares RG, Marinkovic G, Cotoi OS, Schiopu A. Innate Immune Mechanisms in Myocardial Infarction – An Update. Rev Romana Med Lab. 2017;26(1):9–20. doi: 10.1515/rrlm-2017-0031MaresRGMarinkovicGCotoiOSSchiopuAInnate Immune Mechanisms in Myocardial Infarction – An Update201726192010.1515/rrlm-2017-0031Open DOISearch in Google Scholar
Mares RG, Manu D, Szabo IA, et al. Studying the Innate Immune Response to Myocardial Infarction in a Highly Efficient Experimental Animal Model. Romanian Journal of Cardiology. 2021;31(3):573–585. doi: 10.47803/rjc.2021.31.3.573MaresRGManuDSzaboIAStudying the Innate Immune Response to Myocardial Infarction in a Highly Efficient Experimental Animal Model202131357358510.47803/rjc.2021.31.3.573Open DOISearch in Google Scholar
Mares R, Sabău A, Cocuz I, et al. S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction. Romanian Journal of Morphology and Embryology. 2023;64:151–158. doi: 10.47162/RJME.64.2.04MaresRSabăuACocuzIS100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction20236415115810.47162/RJME.64.2.04Open DOISearch in Google Scholar
Schiopu A, Björkbacka H, Narasimhan G, et al. Elevated soluble LOX-1 predicts risk of first-time myocardial infarction. Ann Med. 2023;55(2):2296552. doi: 10.1080/07853890.2023.2296552SchiopuABjörkbackaHNarasimhanGElevated soluble LOX-1 predicts risk of first-time myocardial infarction2023552229655210.1080/07853890.2023.2296552Open DOISearch in Google Scholar
Grufman H, Yndigegn T, Gonçalves I, Nilsson J, Schiopu A. Elevated IL-27 in patients with acute coronary syndrome is associated with adverse ventricular remodeling and increased risk of recurrent myocardial infarction and cardiovascular death. Cytokine. 2019;122:154208. doi: 10.1016/j.cyto.2017.11.002GrufmanHYndigegnTGonçalvesINilssonJSchiopuAElevated IL-27 in patients with acute coronary syndrome is associated with adverse ventricular remodeling and increased risk of recurrent myocardial infarction and cardiovascular death201912215420810.1016/j.cyto.2017.11.002Open DOISearch in Google Scholar
Marinković G, Grauen Larsen H, Yndigegn T, et al. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction. Eur Heart J. 2019;40(32):2713–2723. doi: 10.1093/eurheartj/ehz461MarinkovićGGrauen LarsenHYndigegnTInhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction201940322713272310.1093/eurheartj/ehz461Open DOISearch in Google Scholar
Jalbani J, Bhatti KI, Sallar MT, et al. The Role of Neutrophil to Lymphocyte Ratio and its Common Clinical Outcomes Among Patients with Non-ST Elevation Acute Coronary Syndrome. J Saudi Heart Assoc. 2023;35(2):177–182. doi: 10.37616/2212-5043.1340JalbaniJBhattiKISallarMTThe Role of Neutrophil to Lymphocyte Ratio and its Common Clinical Outcomes Among Patients with Non-ST Elevation Acute Coronary Syndrome202335217718210.37616/2212-5043.1340Open DOISearch in Google Scholar
Tudurachi BS, Anghel L, Tudurachi A, Sascău RA, Stătescu C. Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients. Int J Mol Sci. 2023;24(18):14378. doi: 10.3390/ijms241814378TudurachiBSAnghelLTudurachiASascăuRAStătescuCAssessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients202324181437810.3390/ijms241814378Open DOISearch in Google Scholar
Khan UH, Pala MR, Hafeez I, Shabir A, Dhar A, Rather HA. Prognostic value of hematological parameters in older adult patients with acute coronary syndrome undergoing coronary intervention: a single centre prospective study. J Geriatr Cardiol. 2023;20(8):596–601. doi: 10.26599/1671-5411.2023.08.008KhanUHPalaMRHafeezIShabirADharARatherHAPrognostic value of hematological parameters in older adult patients with acute coronary syndrome undergoing coronary intervention: a single centre prospective study202320859660110.26599/1671-5411.2023.08.008Open DOISearch in Google Scholar
Ha ET, Yee A, Peterson SJ, et al. Neutrophil-to-lymphocyte ratio and prognosis in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Cardiovascular Revascularization Medicine. Published online September 12, 2023. doi: 10.1016/j.carrev.2023.09.003HaETYeeAPetersonSJNeutrophil-to-lymphocyte ratio and prognosis in patients undergoing percutaneous coronary intervention for acute coronary syndromePublished online September 12, 2023.10.1016/j.carrev.2023.09.003Open DOISearch in Google Scholar
Wang W, Liu L, Ning Z, Che L, Li X. The neutrophil-lymphocyte ratio to predict poor prognosis of critical acute myocardial infarction patients: a retrospective cohort study. Biochem Med (Zagreb). 2023;33(1):010702. doi: 10.11613/BM.2023.010702WangWLiuLNingZCheLLiXThe neutrophil-lymphocyte ratio to predict poor prognosis of critical acute myocardial infarction patients: a retrospective cohort study202333101070210.11613/BM.2023.010702Open DOISearch in Google Scholar
Shumilah AM, Othman AM, Al-Madhagi AK. Accuracy of neutrophil to lymphocyte and monocyte to lymphocyte ratios as new inflammatory markers in acute coronary syndrome. BMC Cardiovasc Disord. 2021;21(1):422. doi: 10.1186/s12872-021-02236-7ShumilahAMOthmanAMAl-MadhagiAKAccuracy of neutrophil to lymphocyte and monocyte to lymphocyte ratios as new inflammatory markers in acute coronary syndrome202121142210.1186/s12872-021-02236-7Open DOISearch in Google Scholar